Bio-Link Biological Applied Technologies (Shanghai) Co., Ltd., a leading provider of life sciences industry solutions in China, has entered into a strategic partnership with French bioprocessing company Verdot. The collaboration, facilitated by Cathay Capital, will position Bio-Link as the primary distributor of Verdot’s innovative chromatography columns within the Chinese market.
Bio-Link specializes in the development and production of key processing equipment and materials for a range of biological products, including vaccines, antibodies, cell therapies, and gene therapies. Their comprehensive portfolio encompasses the entire bioprocess spectrum, from upstream cell culture to downstream processes such as chromatography purification, filtration, and ultrafiltration, as well as process development services.
Verdot, a pioneer in downstream bioprocessing technology since 1950 and headquartered in Riom, France, is renowned for its purification solutions serving the biopharmaceutical and food processing sectors. Their product range includes chromatography columns, skids, and tangential flow filtration systems that are essential for purifying, concentrating, and separating biomolecules across various modalities, from monoclonal antibodies and recombinant proteins to adeno-associated virus (AAV), lentiviral, and mRNA-based vaccines.- Flcube.com
